Biotage Temettü
Temettü kriter kontrolleri 3/6
Biotage is a dividend paying company with a current yield of 1.01% that is well covered by earnings.
Anahtar bilgiler
1.0%
Temettü verimi
-0.02%
Geri Alım Getirisi
Toplam Hissedar Getirisi | 1.0% |
Gelecekteki Temettü Verimi | 1.5% |
Temettü Büyümesi | -22.9% |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | SEK 1.600 |
Ödeme oranı | 50% |
Son temettü güncellemeleri
Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Recent updates
Earnings Miss: Biotage AB (publ) Missed EPS By 15% And Analysts Are Revising Their Forecasts
Oct 26Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings
Sep 17Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next
Jul 19Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?
Jun 08Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?
May 21Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next
Apr 08Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)
Feb 22Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%
Feb 21Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 18Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)
Jan 07At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?
Dec 08Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)
Oct 27Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?
Oct 27Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)
Oct 07Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?
Jul 10A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jun 25Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?
May 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 23Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: BIOT's dividend payments have been volatile in the past 10 years.
Büyüyen Temettü: BIOT's dividend payments have increased over the past 10 years.
Piyasaya Karşı Temettü Getirisi
Biotage Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (BIOT) | 1.0% |
Pazarın Alt %25'i (SE) | 1.6% |
Pazarın En İyi %25'i (SE) | 4.5% |
Sektör Ortalaması (Life Sciences) | 0.7% |
Analist tahmini (BIOT) (3 yıla kadar) | 1.5% |
Önemli Temettü: BIOT's dividend (1.01%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (1.55%).
Yüksek Temettü: BIOT's dividend (1.01%) is low compared to the top 25% of dividend payers in the Swedish market (4.49%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonably low payout ratio (49.8%), BIOT's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its reasonable cash payout ratio (52.7%), BIOT's dividend payments are covered by cash flows.